206 related articles for article (PubMed ID: 11454999)
1. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.
Depowski PL; Rosenthal SI; Ross JS
Mod Pathol; 2001 Jul; 14(7):672-6. PubMed ID: 11454999
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
[TBL] [Abstract][Full Text] [Related]
3. A Clinical Analysis of PTEN Expressions in Breast Cancers.
Cho HJ; Kim JS; Kim KH; Ahn CH; Park WC; Oh SJ; Jung SS; Lim KW; Im SA
Cancer Res Treat; 2003 Apr; 35(2):102-8. PubMed ID: 26680922
[TBL] [Abstract][Full Text] [Related]
4. Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast.
Lee JS; Kim HS; Kim YB; Lee MC; Park CS; Min KW
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):205-10. PubMed ID: 15551732
[TBL] [Abstract][Full Text] [Related]
5. Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.
Shoman N; Klassen S; McFadden A; Bickis MG; Torlakovic E; Chibbar R
Mod Pathol; 2005 Feb; 18(2):250-9. PubMed ID: 15475931
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
Saal LH; Holm K; Maurer M; Memeo L; Su T; Wang X; Yu JS; Malmström PO; Mansukhani M; Enoksson J; Hibshoosh H; Borg A; Parsons R
Cancer Res; 2005 Apr; 65(7):2554-9. PubMed ID: 15805248
[TBL] [Abstract][Full Text] [Related]
7. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated PTEN-PKB and negative receptor status in human breast cancer.
Shi W; Zhang X; Pintilie M; Ma N; Miller N; Banerjee D; Tsao MS; Mak T; Fyles A; Liu FF
Int J Cancer; 2003 Mar; 104(2):195-203. PubMed ID: 12569575
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.
Chung MJ; Jung SH; Lee BJ; Kang MJ; Lee DG
Pathol Int; 2004 Jan; 54(1):10-5. PubMed ID: 14674989
[TBL] [Abstract][Full Text] [Related]
10. [Expression of PTEN protein and its correlation with p27kip1 and cyclin D1 expression in primary breast cancer].
Lin Q; Zhuang YZ; Xu DP; Ye JX; Chen PQ
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):246-9. PubMed ID: 12839686
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
12. [Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma].
Zheng HC; Chen Y; Kuang LG; Yang L; Li JY; Wu DY; Zhang SM; Xin Y
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):13-6. PubMed ID: 12678979
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of a new tumor suppression gene PTEN in primary renal cell carcinoma.
Guo SP; Zhai YQ; Wang WL; Ma FC
Ai Zheng; 2002 Jun; 21(6):582-7. PubMed ID: 12452054
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.
Perren A; Weng LP; Boag AH; Ziebold U; Thakore K; Dahia PL; Komminoth P; Lees JA; Mulligan LM; Mutter GL; Eng C
Am J Pathol; 1999 Oct; 155(4):1253-60. PubMed ID: 10514407
[TBL] [Abstract][Full Text] [Related]
15. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
McMenamin ME; Soung P; Perera S; Kaplan I; Loda M; Sellers WR
Cancer Res; 1999 Sep; 59(17):4291-6. PubMed ID: 10485474
[TBL] [Abstract][Full Text] [Related]
16. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer.
Halvorsen OJ; Haukaas SA; Akslen LA
Clin Cancer Res; 2003 Apr; 9(4):1474-9. PubMed ID: 12684422
[TBL] [Abstract][Full Text] [Related]
17. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
20. Loss of PTEN expression in neuroendocrine pancreatic tumors.
Krausch M; Raffel A; Anlauf M; Schott M; Willenberg H; Lehwald N; Hafner D; Cupisti K; Eisenberger CF; Knoefel WT
Horm Metab Res; 2011 Nov; 43(12):865-71. PubMed ID: 22105477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
